This invention provides novel β-lactamase inhibitors of the aryl- and heteroarylsulfonamidomethylphosphonate monoester class having nitrogen-based cations or quarternary ammonium groups. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazidime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases. Formula (I) or pharmaceutically acceptable salt thereof.
[EN] POLYCATIONIC AMPHIPHILES AND POLYMERS THEREOF AS ANTIMICROBIAL AGENTS AND METHODS USING SAME<br/>[FR] COMPOSÉS AMPHIPHILES POLYCATIONIQUES ET LEURS POLYMÈRES UTILISABLES EN TANT QU'AGENTS ANTIMICROBIENS ET LEURS PROCÉDÉS D'UTILISATION
申请人:TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
公开号:WO2016172436A1
公开(公告)日:2016-10-27
The present invention includes novel polycationic amphiphilic compounds useful as antimicrobial agents. The present invention further includes novel polymers of polycationic amphiphilic compounds useful as antimicrobial agents. The present invention further includes methods useful for removing microorganisms and/or biofilm-embedded microorganisms from a surface. The present invention further includes compositions and methods useful for preventing or reducing the growth or proliferation of microorganisms and/or biofilm-embedded microorganisms on a surface.
[EN] IMIDAZOL- OR 1,2,4-TRIAZOL-DERIVATIVES AND THEIR USE<br/>[FR] DÉRIVÉS D'IMIDAZOLE OU DE 1,2,4-TRIAZOL ET LEUR UTILISATION
申请人:UNIV LILLE II DROIT & SANTE
公开号:WO2015189330A1
公开(公告)日:2015-12-17
The present invention is directed to novel compounds of formula (I), pharmaceutically acceptable salts or solvates thereof, and their use.
本发明涉及公式(I)的新化合物,其药学上可接受的盐或溶剂,以及它们的用途。
PHOTOBASE GENERATOR
申请人:SAN-APRO LTD.
公开号:US20160009737A1
公开(公告)日:2016-01-14
There is provided a photobase generator and a photosensitive resin composition containing the photobase generator. The photobase generator includes an ammonium salt represented by general formula (1). In formula (1), R
1
to R
4
independently represent an alkyl group having 1 to 18 carbon atoms or Ar, wherein at least one of R
1
to R
4
represents Ar; Ar represents an aryl group having 6 to 14 carbon atoms (excluding carbon atoms contained in a substituent as mentioned below), wherein some of hydrogen atoms in the aryl group may be independently substituted by an alkyl group having 1 to 18 carbon atoms or the like; Y
+
represents an ammonio group represented by general formula (2) or (3); and E represents a hydrogen atom or a group represented by general formula (5).
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
申请人:AMGEN INC.
公开号:US20140364455A1
公开(公告)日:2014-12-11
The present invention provides processes for making 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid as well as intermediates and processes for making the intermediates. Also provided are crystalline forms of the compound and the intermediates.